Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University

About this trial

The global distribution of primary ophthalmic medical resources is uneven, and the traditional eye disease screening model has problems such as low efficiency, high cost and limited coverage. With the development of artificial intelligence and other technologies, it provides technical support for the construction of intelligent mobile screening model for eye diseases. The investigator's team has developed the 5G intelligent ophthalmic vehicle and served tens of thousands of people in 108 cities nationwide, initially verifying the feasibility of the new intelligent mobile screening model. However, the application effect, acceptance and influencing factors of this model in different regions are not clear, and there is a lack of economic benefit analysis based on real-world data. In this study, the investigators will conduct a cross-sectional study of large-scale population screening for blinding eye diseases in grassroots areas through the smart mobile screening model, focusing on the screening effectiveness and cost-effectiveness of the smart mobile screening model, integrating real-world multimodal eye health data, developing multiple smart screening analysis models, and exploring its adaptability and direction of improvement in grassroots areas.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥ 7 years

Voluntary informed consent

Disqualifiers

None

Trial population

community sample or primary care clinic

Trial design

Design model

Ecologic or community

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

15,000 Participants
are grouped into 1 trial group
Group A: Intelligent Mobile Group

Trial outcomes

Primary outcomes

1

Cost-effectiveness

Incremental Cost per True Positive Case Detected

Time frame
Baseline,6months,12months

Secondary outcomes

1

Eye disease detection rate

Time frame
Baseline,6months,12months
2

Accuracy of multiple intelligent screening analysis models

Time frame
Baseline
3

Screening participation rate

Time frame
baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: